Search results for: 'drug ad pfas'

21 Sep 2022  |  North America  |  Market Research

Drinking Water PFAS Treatment—United States: Forecast to 2026

Future Growth Potential of Sample Testing to Help Map the Presence of PFAS

Infographics

×

Growing concerns regarding the presence of perfluoroalkyl and polyfluoroalkyl substances (PFAS) in surface water, groundwater, wastewater, soil, and air are making state and national level regulations in the United States regarding permissible contaminant limits more stringent. There are growing efforts among municipal utilities and different indus...

PFAS are highly persistent in the environment and are associated with a wide range of serious health risks, resulting in increasing demand for effective management solutions. This study offers a comprehensive analysis of the drinking water PFAS management industry in the United States, highlighting important growth drivers and restraints. The ne...

The increasing disposable incomes in developing countries have contributed to a sedentary lifestyle worldwide. The advent of food delivery apps has also increased accessibility to various culinary delights. These factors have contributed mainly to obesity and other lifestyle diseases. People with a body mass index (BMI) of more than or equal to...

Per- and polyfluoroalkyl substances (PFAS) present substantial environmental and health risks. Their complex structure makes them resistant to natural breakdown and allows them to accumulate in living organisms, posing a potential health risk. Growing evidence of PFAS contamination in surface water, groundwater, wastewater, soil, and air is compell...

This research service overviews the global ADC market and provides a 6-year revenue forecast from 2023 to 2028. An ADC comprises multiple components such as the antibody, conjugation chemistry, linker, and payload. Many companies are working on each component while others only develop ADCs, which makes the market highly competitive. The development...

09 Sep 2024  |  Global  |  Technology Research

AI-based Drug Repurposing Market, Growth Opportunities, Global, 2024-2029

AI-based Drug Repurposing is emerging as a new and faster approach to bringing drugs to patients.

Infographics

×

This study analyzes the emergence of AI-based drug repurposing and examines the factors driving and hindering adoption. The limitation of traditional drug discovery has led to the growing interest in AI -based drug repurposing, which offers numerous advantages in terms of time, speed, and cost. AI-based drug repurposing has been explored across dif...

Drug-resistant bacteria, or superbugs, pose a serious threat to human health. Developing new antibacterial drugs requires a great deal of time, effort, expenditure, and scientific research, making it a less-attractive segment for investment by pharmaceutical companies. This research service focuses on the global antibacterial drugs (antibiotics) ma...

05 Sep 2022  |  Global  |  Technology Research

Technology Growth Opportunities for Exosome-Mediated Drug Delivery

Exosomes Are Promising Delivery Carriers for Advanced Therapeutics

Infographics

×

Exosome-mediated drug delivery is a promising alternative to conventional drug delivery methods, making rapid strides in the biopharmaceutical industry because of the safety and efficacy advantages exosomes offer as nanocarriers over synthetic nanoparticles. The widely explored concepts of nanomedicine, nucleic acid therapeutics, and cell-free vacc...

Antibody-drug conjugates (ADCs) are therapies that target cancer cells with antigen-specific antibodies and highly toxic payloads. ADCs are currently generating interest among drug developers, contract manufacturing companies, regulatory agencies, and other stakeholders. The rise in the number of drug approvals has also sparked interest in further ...